86 related articles for article (PubMed ID: 28543105)
41. Inflammatory myofibroblastic tumor of the uterus: clinical and pathologic review of 10 cases including a subset with aggressive clinical course.
Parra-Herran C; Quick CM; Howitt BE; Dal Cin P; Quade BJ; Nucci MR
Am J Surg Pathol; 2015 Feb; 39(2):157-68. PubMed ID: 25321329
[TBL] [Abstract][Full Text] [Related]
42. Low-grade sarcomas with CD34-positive fibroblasts and low-grade myofibroblastic sarcomas.
Fisher C
Ultrastruct Pathol; 2004; 28(5-6):291-305. PubMed ID: 15764578
[TBL] [Abstract][Full Text] [Related]
43. High-grade myofibroblastic sarcoma in the liver: A case report.
Wen J; Zhao W; Li C; Shen JY; Wen TF
World J Gastroenterol; 2017 Oct; 23(38):7054-7058. PubMed ID: 29097878
[TBL] [Abstract][Full Text] [Related]
44. A novel ALK rearrangement in an inflammatory myofibroblastic tumor in a neonate.
Owusu-Brackett N; Johnson R; Schindel DT; Koduru P; Cope-Yokoyama S
Cancer Genet; 2013; 206(9-10):353-6. PubMed ID: 24290361
[TBL] [Abstract][Full Text] [Related]
45. Comparison of the clinical and immunohistochemical features, including anaplastic lymphoma kinase (ALK) and p53, in inflammatory myofibroblastic tumours.
Jiang YH; Cheng B; Ge MH; Cheng Y; Zhang G
J Int Med Res; 2009; 37(3):867-77. PubMed ID: 19589272
[TBL] [Abstract][Full Text] [Related]
46. Low-grade abdominopelvic sarcoma with myofibroblastic features (low-grade myofibroblastic sarcoma): clinicopathological, immunohistochemical, molecular genetic and ultrastructural study of two cases with literature review.
Agaimy A; Wünsch PH; Schroeder J; Gaumann A; Dietmaier W; Hartmann A; Hofstaedter F; Mentzel T
J Clin Pathol; 2008 Mar; 61(3):301-6. PubMed ID: 17513510
[TBL] [Abstract][Full Text] [Related]
47. Expression of ALK1 and p80 in inflammatory myofibroblastic tumor and its mesenchymal mimics: a study of 135 cases.
Cessna MH; Zhou H; Sanger WG; Perkins SL; Tripp S; Pickering D; Daines C; Coffin CM
Mod Pathol; 2002 Sep; 15(9):931-8. PubMed ID: 12218210
[TBL] [Abstract][Full Text] [Related]
48. Inflammatory Myofibroblastic Tumor of the Tongue. Report of a Pediatric Case and Review of the Literature.
Caporalini C; Moscardi S; Tamburini A; Pierossi N; Di Maurizio M; Buccoliero AM
Fetal Pediatr Pathol; 2018 Apr; 37(2):117-125. PubMed ID: 29336647
[TBL] [Abstract][Full Text] [Related]
49. Pseudosarcomatous myofibroblastic proliferations of the bladder: a clinicopathologic study of 42 cases.
Harik LR; Merino C; Coindre JM; Amin MB; Pedeutour F; Weiss SW
Am J Surg Pathol; 2006 Jul; 30(7):787-94. PubMed ID: 16819319
[TBL] [Abstract][Full Text] [Related]
50. The myofibroblast: a study of normal, reactive and neoplastic tissues, with an emphasis on ultrastructure. part 2 - tumours and tumour-like lesions.
Eyden B
J Submicrosc Cytol Pathol; 2005 Nov; 37(3-4):231-96. PubMed ID: 16612972
[TBL] [Abstract][Full Text] [Related]
51. Inflammatory myofibroblastic tumor: clinical, morphological, immunohistochemical and molecular features of a pediatric case.
Buccoliero AM; Ghionzoli M; Castiglione F; Paglierani M; Baroni G; Messineo A; Taddei GL
Pathol Res Pract; 2014 Dec; 210(12):1152-5. PubMed ID: 25149504
[TBL] [Abstract][Full Text] [Related]
52. [Clinicopathological analysis of abdominal epithelioid inflammatory myofibroblastic sarcoma in children].
Zhang M; Li JL; Wang RF; Guan WB; Wang LF
Zhonghua Bing Li Xue Za Zhi; 2021 Nov; 50(11):1272-1274. PubMed ID: 34719169
[No Abstract] [Full Text] [Related]
53. Corrigendum to 'Identification of a RNA-seq-based signature to improve prognostics for uterine sarcoma' [Gynecologic Oncology 155 (2019) 499-507].
Zhou JG; Zhao HT; Jin SH; Tian X; Ma H
Gynecol Oncol; 2020 Sep; 158(3):812. PubMed ID: 32709537
[No Abstract] [Full Text] [Related]
54. Corrigendum to 'Silencing KIF18B enhances radiosensitivity: Identification of a promising therapeutic target in sarcoma' [EBioMedicine 61 (2020) 103,056].
Liu W; Yu Z; Tang H; Wang X; Zhang B; Zhao J; Liu X; Zhang J; Wei M
EBioMedicine; 2021 Dec; 74():103710. PubMed ID: 34823109
[No Abstract] [Full Text] [Related]
55. Case Report: Ensartinib for gastric epithelioid inflammatory myofibrosarcoma with STRN-ALK fusion.
Li X; Zheng J; Li X; Chen Y; Liu K; Li F; Lu Z
Front Oncol; 2023; 13():1252221. PubMed ID: 37869075
[TBL] [Abstract][Full Text] [Related]
56. Case report: Epithelioid inflammatory myofibroblastic sarcoma treated with an ALK TKI ensartinib.
Li M; Xing R; Huang J; Shi C; Wei C; Wang H
Front Oncol; 2023; 13():1084456. PubMed ID: 37035183
[TBL] [Abstract][Full Text] [Related]
57. 'ALK oncoproteins in atypical inflammatory myofibroblastic tumours: novel RRBP1-ALK fusions in epithelioid inflammatory myofibroblastic sarcoma'.
J Pathol; 2017 Jun; 242(2):260. PubMed ID: 28543105
[No Abstract] [Full Text] [Related]
58. ALK oncoproteins in atypical inflammatory myofibroblastic tumours: novel RRBP1-ALK fusions in epithelioid inflammatory myofibroblastic sarcoma.
Lee JC; Li CF; Huang HY; Zhu MJ; Mariño-Enríquez A; Lee CT; Ou WB; Hornick JL; Fletcher JA
J Pathol; 2017 Feb; 241(3):316-323. PubMed ID: 27874193
[TBL] [Abstract][Full Text] [Related]
59. Epithelioid inflammatory myofibroblastic sarcoma with VCL-ALK fusion of central nervous system: case report and brief review of the literature.
Chopra S; Maloney N; Wang WL
Brain Tumor Pathol; 2022 Jan; 39(1):35-42. PubMed ID: 34743247
[TBL] [Abstract][Full Text] [Related]
60. Primary epithelioid inflammatory myofibroblastic sarcoma of the brain with EML4::ALK fusion mimicking intra-axial glioma: a case report and brief literature review.
Kim EE; Park CK; Kang KM; Kwak Y; Park SH; Won JK
J Pathol Transl Med; 2024 May; 58(3):141-145. PubMed ID: 38766740
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
